Inventor · disambiguated record
Sumihiro Nomura
Also filed as: NOMURA SUMIHIRO
29 granted patents·7 pending applications·194 citations·filing 1987–2018
96Inventor score
Files withTANABE SEIYAKU CO15MITSUBISHI TANABE PHARMA CORP12NOMURA SUMIHIRO5WELLS KENNETH M2ABDEL-MAGID AHMED F1
Top patents by PatentIndex Score
36 records- 0194US7943582B2Crystalline form of 1-(β-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrateMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted May 17, 2011·31 cites·7 claims
- 0293US7943788B2Glucopyranoside compoundMITSUBISHI TANABE PHARMA CORP·Filed 2005·Granted May 17, 2011·36 cites·26 claims
- 0389US7026501B2Inhibitors of α4 mediated cell adhesionTANABE SEIYAKU CO·Filed 2001·Granted Apr 11, 2006·26 cites·13 claims
- 0486US8513202B2Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrateNOMURA SUMIHIRO·Filed 2011·Granted Aug 20, 2013·9 cites·5 claims
- 0586US8222219B2Glucopyranoside compoundNOMURA SUMIHIRO·Filed 2011·Granted Jul 17, 2012·11 cites·25 claims
- 0683US7935674B2Indole derivativesMITSUBISHI TANABE PHARMA CORP·Filed 2009·Granted May 3, 2011·3 cites·19 claims
- 0779US7851617B2Indole derivativesMITSUBISHI TANABE PHARMA CORP·Filed 2007·Granted Dec 14, 2010·6 cites·12 claims
- 0878US9024009B2Process for the preparation of compounds useful as inhibitors of SGLTABDEL-MAGID AHMED F·Filed 2008·Granted May 5, 2015·6 cites·31 claims
- 0978US8202984B2Glucopyranoside compoundNOMURA SUMIHIRO·Filed 2011·Granted Jun 19, 2012·4 cites·16 claims
- 1077US8785403B2Glucopyranoside compoundNOMURA SUMIHIRO·Filed 2012·Granted Jul 22, 2014·3 cites·26 claims
- 1171US4839360ALactam derivativesTANABE SEIYAKU CO·Filed 1987·Granted Jun 13, 1989·9 cites·24 claims
- 1270US6388078B1S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 2001·Granted May 14, 2002·1 cites·1 claims
- 1369US6015901AS type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 1998·Granted Jan 18, 2000·7 cites·10 claims
- 1468US2018282363A1Glucopyranoside compoundMITSUBISHI TANABE PHARMA CORP·Filed 2018·Application pending·0 cites
- 1566US7671090B2Inhibitors of α4 mediated cell adhesionMITSUBISHI TANABE PHARMA CORP·Filed 2008·Granted Mar 2, 2010·0 cites·8 claims
- 1665US5332754ANaphthyloxazolidone derivativesTANABE SEIYAKU CO·Filed 1992·Granted Jul 26, 1994·16 cites·11 claims
- 1762US2014296506A1Glucopyranoside compoundMITSUBISHI TANABE PHARMA CORP·Filed 2014·Application pending·0 cites
- 1861US7521430B2N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporterMITSUBISHI TANABE PHARMA CORP·Filed 2004·Granted Apr 21, 2009·1 cites·7 claims
- 1961US2013289109A1Inhibitors of alpha4 mediated cell adhesionMITSUBISHI TANABE PHARMA CORP·Filed 2013·Application pending·0 cites
- 2058US7456217B2Inhibitors of alpha4 mediated cell adhesionMITSUBISHI TANABE PHARMA CORP·Filed 2005·Granted Nov 25, 2008·0 cites·8 claims
- 2157US6114529AS type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 1999·Granted Sep 5, 2000·13 cites·11 claims
- 2257US2016108078A1Glucopyranoside compoundMITSUBISHI TANABE PHARMA CORP·Filed 2015·Application pending·0 cites
- 2356US7872151B2Inhibitors of α4 mediated cell adhesionMITSUBISHI TANABE PHARMA CORP·Filed 2010·Granted Jan 18, 2011·0 cites·3 claims
- 2456US7060832B2Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R”TANABE SEIYAKU CO·Filed 2002·Granted Jun 13, 2006·0 cites·2 claims
- 2554US8501809B2Inhibitors of α4 mediated cell adhesionKAWAGUCHI TAKAYUKI·Filed 2010·Granted Aug 6, 2013·0 cites·8 claims
- 2654US6716983B2S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 2003·Granted Apr 6, 2004·0 cites·3 claims
- 2751US6277992B1S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 2000·Granted Aug 21, 2001·0 cites·4 claims
- 2845US2008027014A1Novel SGLT inhibitorsTANABE SEIYAKU CO·Filed 2007·Application pending·0 cites
- 2944US5510354AImidazopyridine derivativesTANABE SEIYAKU CO·Filed 1995·Granted Apr 23, 1996·2 cites·10 claims
- 3043US5409936AImidazopyridine derivatives for the treatment of hypertensionTANABE SEIYAKU CO·Filed 1992·Granted Apr 25, 1995·4 cites·10 claims
- 3143US2008119422A1Indole DerivativesNOMURA SUMIHIRO·Filed 2006·Application pending·0 cites
- 3242US5268377AImidazoindolizine derivatives process for preparation thereof and use thereof to treat hypertensionTANABE SEIYAKU CO·Filed 1992·Granted Dec 7, 1993·2 cites·26 claims
- 3340US5424316AImidazopyridine derivatives for the treatment of hypertensionTANABE SEIYAKU CO·Filed 1993·Granted Jun 13, 1995·3 cites·16 claims
- 3437US5932732AS type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereofTANABE SEIYAKU CO·Filed 1997·Granted Aug 3, 1999·1 cites·8 claims
- 3532US9522931B2Process for the preparation of compounds useful as inhibitors of SGLT-2WELLS KENNETH M·Filed 2012·Granted Dec 20, 2016·0 cites·20 claims
- 3632US2014206859A1Process for the preparation of compounds useful as inhibitors of sglt-2WELLS KENNETH M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sumihiro Nomura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →